BioLASCO Taiwan Co., Ltd. (6662.TWO)
TWD 33.1
(-3.22%)
TWD 33.1
(-3.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 73.9 Million TWD | 15.14% |
| 2022 | 59.5 Million TWD | -4.69% |
| 2021 | 67.34 Million TWD | -24.2% |
| 2020 | 88.22 Million TWD | 13.76% |
| 2019 | 78.1 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 14.41 Million TWD | 100.23% |
| 2024 Q1 | 7.35 Million TWD | -70.61% |
| 2023 Q4 | 25.03 Million TWD | 46.8% |
| 2023 FY | - TWD | 15.14% |
| 2023 Q3 | 17.05 Million TWD | -15.9% |
| 2023 Q2 | 20.27 Million TWD | 75.56% |
| 2023 Q1 | 11.54 Million TWD | -26.96% |
| 2022 FY | - TWD | -4.69% |
| 2022 Q4 | 15.81 Million TWD | 0.0% |
| 2021 FY | - TWD | -24.2% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 259.813% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 81.224% |
| Level Biotechnology Inc. | 98.7 Million TWD | 25.126% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 265.189% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 202.481% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 392.886% |
| GlycoNex Incorporation | -126.82 Million TWD | 158.272% |
| VBI | -6.97 Million TWD | 1160.011% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 151.431% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -238.854% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 516.924% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 171.326% |
| Visgeneer Inc. | 973 Thousand TWD | -7495.478% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 121.77% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 92.108% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 25.975% |
| Neith Corporation | -33.61 Million TWD | 319.887% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 107.457% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 4354.692% |
| Enimmune corporation | -228.96 Million TWD | 132.278% |
| TaiRx, Inc. | -208.64 Million TWD | 135.421% |
| CHO Pharma, Inc. | -277.73 Million TWD | 126.61% |
| EirGenix Inc. | -664.4 Million TWD | 111.123% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | -6.886% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 106.898% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 165.34% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -112.136% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 218.548% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 381.004% |
| RBC Bioscience Corporation | 36.54 Million TWD | -102.216% |
| BiOptic Inc. | 65.03 Million TWD | -13.632% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 110.829% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 323.911% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 234.579% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 82.954% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 192.297% |
| NaviFUS Corp. | -55.79 Million TWD | 232.456% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 545.258% |
| Sinew Pharma Inc. | -163.63 Million TWD | 145.165% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 220.169% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 61.589% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 132.603% |
| AP Biosciences Inc | -325.51 Million TWD | 122.704% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 107.075% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 306.171% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -153.704% |
| Intech Biopharm Corporation | -219.58 Million TWD | 133.656% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 110.961% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 264.41% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 145.944% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 88.726% |
| TCI GENE Inc. | 25.98 Million TWD | -184.454% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 166.798% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 126.042% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 150.63% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -433.603% |
| PharmaEngine, Inc. | 347.3 Million TWD | 78.721% |
| Savior Lifetec Corporation | 219.6 Million TWD | 66.347% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 57.09% |
| OBI Pharma, Inc. | -855.08 Million TWD | 108.643% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 179.842% |
| Acepodia, Inc. | -764.51 Million TWD | 109.667% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 116.063% |